ロード中...
New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer
Although the overall survival rate of papillary or follicular thyroid cancers is good, anaplastic carcinomas and radio iodine refractory cancers remain a significant therapeutic challenge. Galectin-1 (Gal-1) is overexpressed in tumor cells and tumor-associated endothelial cells, and is broadly impli...
保存先:
| 出版年: | Cells |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8147933/ https://ncbi.nlm.nih.gov/pubmed/34063063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10051112 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|